Author:
Urnauer Sarah,Schmohl Kathrin A.,Tutter Mariella,Schug Christina,Schwenk Nathalie,Morys Stephan,Ziegler Sibylle,Bartenstein Peter,Clevert Dirk-André,Wagner Ernst,Spitzweg Christine
Funder
Cluster of Excellence Nanosystems Initiative Munich
Deutsche Forschungsgemeinschaft
Wilhelm Sander-Stiftung
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference59 articles.
1. Davis GL, Dempster J, Meler JD, Orr DW, Walberg MW, Brown B, et al. Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ Med Cent). 2008;21:266–80.
2. Lu LC, Hsu CH, Hsu C, Cheng AL. Tumor heterogeneity in hepatocellular carcinoma: facing the challenges. Liver Cancer. 2016;5:128–38.
3. Hammoud GM, Ibdah JA. Are we getting closer to understanding intratumor heterogeneity in hepatocellular carcinoma? Hepatobiliary Surg Nutr. 2016;5:188–90.
4. Al-Lazikani B, Banerji U, Workman P. Combinatorial drug therapy for cancer in the post-genomic era. Nat Biotechnol. 2012;30:679–92.
5. Broda E, Mickler FM, Lachelt U, Morys S, Wagner E, Brauchle C. Assessing potential peptide targeting ligands by quantification of cellular adhesion of model nanoparticles under flow conditions. J Control Release. 2015;213:79–85.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献